{
    "response": "**Overall Treatment Decision:** Yes\n\n**Specific Treatment Recommendations:**\n\n*   **Treatment:** Intravenous Methylprednisolone\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Standard acute treatment for disabling demyelinating relapse Reduces duration of relapse and accelerates functional recovery\n\n*   **Treatment:** Proton Pump Inhibitor (e.g., Omeprazole)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** Gastric protection against high-dose corticosteroid therapy\n\n*   **Treatment:** Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\n*   **Initiation Timing:** Delay\n*   **Clinical Reasoning for Timing:** Requires confirmed diagnosis (e.g., McDonald criteria for MS vs AQP4+ NMOSD) Requires screening for latent infections (e.g., TB, Hepatitis) before initiation\n\n*   **Treatment:** Multidisciplinary Rehabilitation (Physiotherapy/Occupational Therapy)\n*   **Initiation Timing:** Start Now\n*   **Clinical Reasoning for Timing:** To address gait instability, spasticity, and functional deficits\n\n\ntreatments = [{\"treatment\": \"Intravenous Methylprednisolone\", \"timing\": \"Start Now\", \"reasons\": [\"Standard acute treatment for disabling demyelinating relapse\", \"Reduces duration of relapse and accelerates functional recovery\"]}, {\"treatment\": \"Proton Pump Inhibitor (e.g., Omeprazole)\", \"timing\": \"Start Now\", \"reasons\": [\"Gastric protection against high-dose corticosteroid therapy\"]}, {\"treatment\": \"Disease Modifying Therapy (e.g., Ocrelizumab, Natalizumab)\", \"timing\": \"Delay\", \"reasons\": [\"Requires confirmed diagnosis (e.g., McDonald criteria for MS vs AQP4+ NMOSD)\", \"Requires screening for latent infections (e.g., TB, Hepatitis) before initiation\"]}, {\"treatment\": \"Multidisciplinary Rehabilitation (Physiotherapy/Occupational Therapy)\", \"timing\": \"Start Now\", \"reasons\": [\"To address gait instability, spasticity, and functional deficits\"]}]"
}